0001415889-24-005098.txt : 20240223 0001415889-24-005098.hdr.sgml : 20240223 20240223173325 ACCESSION NUMBER: 0001415889-24-005098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Earnhardt Lisa D CENTRAL INDEX KEY: 0001530893 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 24672801 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE STREET 2: C/O INTERSECT ENT, INC. CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER NAME: FORMER CONFORMED NAME: Earnhardt Lisa DATE OF NAME CHANGE: 20110922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02232024_100219.xml X0508 4 2024-02-21 0000001800 ABBOTT LABORATORIES ABT 0001530893 Earnhardt Lisa D 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT 0 Common shares without par value 2024-02-21 4 A 0 17240 0 A 92677 D Option (right to buy) 116.98 2024-02-21 4 A 0 64787 0 A 2025-02-21 2034-02-20 Common Shares 64787 64787 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,595 on February 21, 2025, 21,596 on February 21, 2026, and 21,596 on February 21, 2027. /s/ Lisa D. Earnhardt, by Jessica H. Paik, Attorney-in-Fact 2024-02-23